KRRO Korro Bio, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$9,64
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$5,2052 haftanın en düşüğü
$55,8952 haftanın en yükseği
Piyasa Değeri (MRQ)
$142M
P/E (TTM)
-1.0
Hisse Başına Kâr (TTM)
$-10.01
Gelir (TTM)
$2M
rozetleriniz
52 Haftlık Aralık
$5–$56
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$20
P/E
-1.0
ROE
-97.7%
Net Kâr Marjı
-4477.1%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
KRRO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$9.64
Piyasa Değeri (MRQ)
$142M
P/E (TTM)
-1.0
Hisse Başına Kâr (TTM)
$-10.01
Gelir (TTM)
$2M
ROE (TTM)
-97.7%
52 Haftlık Aralık
$5–$56
KRRO Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 06 Kasım 2023 | 1-for-50 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$6M2019-12-31 → 2025-12-31
Hisse Başına Kâr$-12.482022-12-31 → 2025-12-31
Serbest Nakit Akışı$-79M2019-12-31 → 2025-12-31
Net kar marjı-4477.1%2019-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | KRRO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -1.05Y ort. ≈-1.6 | ≈-1.6 | · | · | |
| F/S (TTM) | 59.55Y ort. ≈266.7 | ≈266.7 | 29.5 | Aşırı değerli | |
| F/D (MRQ) | 1.45Y ort. ≈18.5 | ≈18.5 | 1.9 | Adil değer | |
| Fiyat / Serbest Nakit Akışı (TTM) | -2.15Y ort. ≈-30.8 | ≈-30.8 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -2.15Y ort. ≈-32.3 | ≈-32.3 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 2.75Y ort. ≈2.0 | ≈2.0 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | KRRO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -4625.5%5Y ort. ≈-2183.6% | ≈-2183.6% | -1906.4% | Aynı seviyede | |
| EBITDA Margin (FAVÖK Marjı) | -1906.4%5Y ort. ≈-2183.6% | ≈-2183.6% | -1906.4% | Aynı seviyede | |
| Vergi Öncesi Kar Marjı (TTM) | -4441.9%5Y ort. ≈-2033.5% | ≈-2033.5% | -3650.4% | En üst düzey | |
| Net Kâr Marjı (TTM) | -4477.1%5Y ort. ≈-2038.9% | ≈-2038.9% | -1834.5% | Aynı seviyede | |
| ROA (TTM) | -62.0%5Y ort. ≈-49.7% | ≈-49.7% | -69.0% | Aynı seviyede | |
| ROE (TTM) | -97.7%5Y ort. ≈-306.4% | ≈-306.4% | -81.2% | Zayıf | |
| ROIC | -238.2%5Y ort. ≈-102.3% | ≈-102.3% | -75.7% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | KRRO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 9.65Y ort. ≈9.1 | ≈9.1 | 6.5 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 6.35Y ort. ≈7.6 | ≈7.6 | 4.1 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | KRRO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 181.5% | · | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -45.6% | · | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | -29.6% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | KRRO | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.0 | ≈0.0 | 0.0 | En üst düzey | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$112.1K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
14.7%
Sonraki Rapor
Kas 10, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 18, 2026 | $-1.07 | $-1.48 | 27.7% |
| 31 Mart 2026 | May 19, 2026 | $-1.69 | $-1.88 | 10.0% |
| 31 Aralık 2025 | $-1.65 | $-2.11 | 21.7% | |
| 30 Eylül 2025 | $-1.92 | $-2.65 | 27.4% | |
| 30 Haziran 2025 | $-2.74 | $-2.62 | -4.8% | |
| 31 Mart 2025 | $-2.49 | $-2.66 | 6.2% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $2M | $0 | $0 | $14M | $37M | $29M | |
| R&D Expense | $66M | $64M | $57M | $42M | $61M | $37M | $19M | |
| SG&A Expense | $28M | $31M | $27M | $17M | $37M | $27M | $15M | |
| Operating Expenses | $128M | $94M | $85M | $59M | $98M | $65M | $50M | |
| Operating Income | $-122M | $-92M | $-85M | $-59M | $-84M | $-28M | $-21M | |
| Interest Expense | · | · | · | $961.0K | $764.0K | $0 | · | |
| Interest Income | · | · | · | $1M | $397.0K | $994.0K | $2M | |
| Other Non-op | $5M | $8M | $3M | $976.0K | $-266.0K | · | · | |
| Pretax Income | $-117M | $-83M | $-81M | $-58M | $-85M | $-26M | $-19M | |
| Income Tax | $637.0K | $141.0K | $27.0K | $10.0K | $15.0K | $35.0K | $0 | |
| Net Income | $-117M | $-84M | $-81M | $-58M | $-85M | $-27M | $-19M | |
| EPS (Basic) | $-12.48 | $-9.37 | $-53.08 | $-227.42 | · | · | · | |
| EPS (Diluted) | $-12.48 | $-9.37 | $-53.08 | $-227.42 | · | · | · | |
| Shares (Basic) | 9,395,402 | 8,920,561 | 1,529,321 | 255,175 | · | · | · | |
| Shares (Diluted) | 9,395,402 | 8,920,561 | 1,529,321 | 255,175 | · | · | · | |
| EBITDA | $-122M | $-92M | $-85M | · | $-84M | $-28M | $-21M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22M | $56M | $166M | $36M | $80M | $220M | $200M | |
| Short-term Investments | $53M | $70M | $0 | $19M | · | · | · | |
| Prepaid Expense | $6M | $4M | $3M | $1M | $4M | $5M | $4M | |
| Other Current Assets | · | · | · | $255.0K | $185.0K | $102.0K | $199.0K | |
| Current Assets | $82M | $132M | $173M | $57M | $135M | $225M | $221M | |
| PP&E (Net) | $8M | $28M | $16M | $10M | $6M | $7M | $2M | |
| PP&E (Gross) | $19M | $35M | $24M | $14M | $10M | $10M | $4M | |
| Accum. Depreciation | $11M | $7M | $8M | $4M | $4M | $3M | $2M | |
| Other Non-current Assets | $2M | $3M | $3M | $228.0K | · | · | $101.0K | |
| Total Assets | $114M | $226M | $222M | $74M | $185M | $265M | $223M | |
| Accounts Payable | $2M | $4M | $7M | $3M | $3M | $6M | $1M | |
| Accrued Liabilities | $8M | $6M | $10M | $3M | $6M | $7M | $3M | |
| Current Liabilities | $12M | $15M | $19M | $9M | $11M | $27M | $53M | |
| Capital Leases | $41M | $43M | $31M | $209.0K | $29M | $31M | · | |
| Other Non-current Liabilities | $1M | $1M | $1M | $0 | $87.0K | · | · | |
| Total Liabilities | $62M | $66M | $52M | $9M | $55M | $72M | $56M | |
| Total Debt | · | · | · | · | $833.0K | · | $180.0K | |
| Common Stock | $9.0K | $9.0K | $8.0K | $0 | $35.0K | $34.0K | $31.0K | |
| Paid-in Capital | $435M | $427M | $353M | $3M | $311M | $288M | $236M | |
| Retained Earnings | $-384M | $-267M | $-183M | $-102M | $-180M | $-95M | $-69M | |
| AOCI | $212.0K | $268.0K | $0 | $-5.0K | $-62.0K | $27.0K | $54.0K | |
| Stockholders' Equity | $51M | $160M | $170M | $-99M | $-42M | $192M | $167M | |
| Liabilities + Equity | $114M | $226M | $222M | $74M | $185M | $265M | $223M | |
| Shares Outstanding | 9,417,295 | 9,377,259 | 8,016,516 | 268,399 | 237,803 | 33,964,000 | 30,844,507 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | · | · | $20M | $22M | $10M | $4M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Restructuring | $4M | $0 | · | · | · | · | · | |
| Operating Cash Flow | $-79M | $-60M | $-67M | $-54M | $-76M | $-45M | $34M | |
| CapEx | $518.0K | $18M | $8M | $5M | $3M | $7M | $1M | |
| Investing Cash Flow | $44M | $-123M | $11M | $11M | $-66M | $10M | $-18M | |
| Debt Issued | · | · | · | · | · | $15M | · | |
| Net Debt Issued | · | · | · | · | · | $15M | · | |
| Stock Issued | · | $0 | $117M | $0 | $1M | $2M | $80M | |
| Net Stock Activity | · | $0 | $117M | · | $1M | $2M | $80M | |
| Financing Cash Flow | $685.0K | $69M | $188M | $18.0K | $1M | $57M | $142M | |
| Net Change in Cash | $-34M | $-114M | $132M | $-43M | $-141M | $22M | $158M | |
| Taxes Paid | $1.0K | $141.0K | $27.0K | $11.0K | · | · | $94.0K | |
| Free Cash Flow | $-79M | $-78M | $-75M | · | $-79M | $-52M | $33M | |
| Levered FCF | · | · | · | · | $-80M | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1906.4% | -4047.1% | · | · | -597.3% | -74.5% | -71.4% | |
| Net Margin | -1834.5% | -3680.4% | · | · | -602.0% | -71.7% | -64.8% | |
| Pretax Margin | -1824.5% | -3674.2% | · | · | -601.9% | -71.6% | · | |
| EBITDA Margin | -1906.4% | -4047.1% | · | · | -597.3% | -74.5% | -71.4% | |
| ROA | -69.0% | -37.3% | -55.0% | · | -37.6% | -10.9% | -14.0% | |
| ROE | -140.8% | -49.2% | -974.8% | · | -60.9% | -13.5% | -34.8% | |
| ROIC | -238.2% | -57.4% | -49.8% | · | -63.8% | -14.3% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.9 | 8.8 | 8.9 | · | 11.8 | 8.5 | 4.2 | |
| Quick Ratio | 6.3 | 8.4 | 8.5 | · | 7.0 | 8.3 | 3.8 | |
| Debt / Equity | · | · | · | · | 0.0 | · | 0.0 | |
| LT Debt / Equity | · | · | · | · | · | · | 0.0 | |
| Interest Coverage | · | · | · | · | -110.0 | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.2 | 0.2 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.46 | $17.11 | $21.20 | · | $3.78 | $5.67 | $5.43 | |
| Revenue / Share | $0.68 | $0.25 | $0.00 | · | · | · | · | |
| Cash Flow / Share | $-8.36 | $-6.73 | $-44.00 | · | · | · | · | |
| Cash / Share | $2.32 | $5.93 | $20.73 | · | $2.30 | $6.49 | $6.49 | |
| EPS (TTM) | $-12.48 | $-9.37 | $-53.08 | $-227.42 | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 181.5% | · | · | · | -62.0% | · | · | |
| Revenue CAGR 3Y | · | -45.6% | · | · | · | · | · | |
| Revenue CAGR 5Y | -29.6% | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $2M | $0 | $0 | $14M | $37M | $29M | |
| Net Income TTM | $-117M | $-84M | $-81M | $-58M | $-85M | $-27M | $-19M | |
| Market Cap | $75M | $357M | $384M | · | $8.88B | $59.88B | $27.04B | |
| Enterprise Value | · | · | · | · | $8.80B | · | $26.84B | |
| P/E | -0.6 | -4.1 | -0.9 | -0.8 | · | · | · | |
| P/S | 11.8 | 157.2 | · | · | 631.1 | 1619.0 | 934.0 | |
| P/B | 1.5 | 2.2 | 2.3 | · | 67.9 | 311.1 | 161.5 | |
| P / Tangible Book | 1.5 | 2.2 | 2.3 | · | · | 311.1 | · | |
| P / Cash Flow | -1.0 | -5.9 | -5.7 | · | -116.7 | -1325.1 | 790.2 | |
| P / FCF | -1.0 | -4.6 | -5.1 | · | -112.4 | -1154.6 | 815.5 | |
| EV / EBITDA | · | · | · | · | -104.7 | · | -1298.0 | |
| EV / FCF | · | · | · | · | -111.4 | · | 809.5 | |
| EV / Revenue | · | · | · | · | 625.5 | · | 927.0 | |
| Earnings Yield | -155.8% | -24.6% | -110.7% | -118.1% | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1M | $1M | $1M | $3M | $2M | $0 | $0 | $0 | · | · | · | · | · | $0 | |
| R&D Expense | $14M | $13M | $11M | $14M | $20M | $20M | $17M | $16M | $17M | $14M | $15M | $14M | $13M | $15M | $3M | $12M | |
| SG&A Expense | $7M | $7M | $6M | $7M | $7M | $8M | $8M | $7M | $7M | $8M | $11M | $5M | $5M | $5M | $-9M | $9M | |
| Operating Expenses | $20M | $20M | $52M | $20M | $29M | $28M | $25M | $23M | $24M | $21M | $27M | $19M | $18M | $20M | $-6M | $20M | |
| Operating Income | $-20M | $-20M | $-50M | $-19M | $-27M | $-25M | $-23M | $-23M | $-24M | $-21M | $-27M | $-19M | $-18M | $-20M | $6M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $284.0K | · | $263.0K | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $448.0K | $346.0K | $523.0K | · | $351.0K | |
| Other Non-op | $1M | $906.0K | $990.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $656.0K | $786.0K | $481.0K | $619.0K | $617.0K | |
| Pretax Income | $-19M | $-20M | $-49M | $-18M | $-26M | $-23M | $-21M | $-21M | $-22M | $-20M | $-25M | $-18M | $-18M | $-20M | $6M | $-20M | |
| Income Tax | $108.0K | $95.0K | $636.0K | $0 | $1.0K | $0 | $103.0K | $-9.0K | $30.0K | $17.0K | $0 | $0 | $27.0K | $0 | $19.0K | $-23.0K | |
| Net Income | $-19M | $-20M | $-50M | $-18M | $-26M | $-23M | $-21M | $-21M | $-22M | $-20M | $-25M | $-18M | $-18M | $-20M | $6M | $-20M | |
| EPS (Basic) | $-1.07 | $-1.69 | $-5.33 | $-1.92 | $-2.74 | $-2.49 | $-2.24 | $-2.26 | $-2.43 | $-2.44 | $148.03 | $-65.08 | $-63.83 | $-72.20 | $-225.59 | $-0.55 | |
| EPS (Diluted) | $-1.07 | $-1.69 | $-5.33 | $-1.92 | $-2.74 | $-2.49 | $-2.24 | $-2.26 | $-2.43 | $-2.44 | $148.03 | $-65.08 | $-63.83 | $-72.20 | $-225.59 | $-0.55 | |
| Shares (Basic) | 17,618,441 | 11,598,717 | · | 9,391,559 | 9,390,542 | 9,384,266 | · | 9,303,218 | 8,986,545 | 8,019,626 | · | 284,156 | 276,482 | 271,522 | · | 35,247,680 | |
| Shares (Diluted) | 17,618,441 | 11,598,717 | · | 9,391,559 | 9,390,542 | 9,384,266 | · | 9,303,218 | 8,986,545 | 8,019,626 | · | 284,156 | 276,482 | 271,522 | · | 35,247,680 | |
| EBITDA | $-20M | $-20M | · | $-19M | $-27M | $-25M | · | $-23M | $-24M | $-21M | · | $-13M | $-12M | $-21M | · | $-20M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $62M | $22M | $24M | $34M | $64M | $56M | $63M | $91M | $139M | $166M | $42M | $40M | $41M | $36M | $44M | |
| Short-term Investments | $90M | $52M | $53M | $68M | $63M | $51M | $70M | $74M | $66M | · | $0 | · | · | · | $19M | · | |
| Prepaid Expense | $6M | $6M | $6M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $423.0K | $2M | $3M | $1M | $2M | |
| Current Assets | $121M | $120M | $82M | $98M | $103M | $121M | $132M | $153M | $164M | $146M | $173M | $42M | $48M | $69M | $57M | $101M | |
| PP&E (Net) | $7M | $8M | $8M | $24M | $25M | $27M | $28M | $29M | $25M | $21M | $16M | $543.0K | $1M | $2M | $10M | $3M | |
| PP&E (Gross) | $19M | $19M | $19M | $35M | $35M | $35M | $35M | $39M | $34M | $29M | $24M | $4M | $9M | $9M | $14M | $9M | |
| Accum. Depreciation | $11M | $11M | $11M | $11M | $10M | $9M | $7M | $10M | $9M | $9M | $8M | $3M | $8M | $7M | $4M | $6M | |
| Other Non-current Assets | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $3M | · | · | · | $228.0K | · | |
| Total Assets | $163M | $184M | $114M | $162M | $180M | $202M | $226M | $244M | $250M | $198M | $222M | $46M | $79M | $102M | $74M | $136M | |
| Accounts Payable | $4M | $2M | $2M | $2M | $5M | $4M | $4M | $6M | $6M | $5M | $7M | $338.0K | $1M | $3M | $3M | $4M | |
| Accrued Liabilities | $5M | $10M | $8M | $6M | $6M | $4M | $6M | $5M | $6M | $5M | $10M | $8M | $5M | $6M | $3M | $5M | |
| Current Liabilities | $13M | $15M | $12M | $15M | $17M | $13M | $15M | $14M | $12M | $11M | $19M | $10M | $8M | $22M | $9M | $20M | |
| Capital Leases | $39M | $40M | $41M | $42M | $42M | $43M | $43M | $42M | $38M | $35M | $31M | $0 | $26M | $26M | $209.0K | $27M | |
| Other Non-current Liabilities | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $717.0K | $1M | $893.0K | $1M | $0 | $0 | $0 | $0 | $79.0K | |
| Total Liabilities | $60M | $64M | $62M | $63M | $65M | $63M | $66M | $64M | $52M | $47M | $52M | $10M | $34M | $48M | $9M | $54M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $12M | · | $8M | |
| Common Stock | $14.0K | $14.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $37.0K | $36.0K | $36.0K | $0 | $35.0K | |
| Paid-in Capital | $526M | $523M | $435M | $433M | $431M | $429M | $427M | $424M | $422M | $354M | $353M | $340M | $337M | $334M | $3M | $327M | |
| Retained Earnings | $-422M | $-403M | $-384M | $-334M | $-316M | $-290M | $-267M | $-245M | $-224M | $-203M | $-183M | $-304M | $-292M | $-281M | $-102M | $-244M | |
| AOCI | $-189.0K | $5.0K | $212.0K | $214.0K | $177.0K | $264.0K | $268.0K | $574.0K | $21.0K | · | $0 | $10.0K | $-6.0K | $-64.0K | $-5.0K | $-376.0K | |
| Stockholders' Equity | $103M | $120M | $51M | $99M | $115M | $139M | $160M | $180M | $198M | $151M | $170M | $37M | $45M | $53M | $-99M | $82M | |
| Liabilities + Equity | $163M | $184M | $114M | $162M | $180M | $202M | $226M | $244M | $250M | $198M | $222M | $46M | $79M | $102M | $74M | $136M | |
| Shares Outstanding | 14,705,646 | 14,422,571 | 9,417,295 | 9,397,984 | 9,390,842 | 9,388,902 | 9,377,259 | 9,318,356 | 9,279,937 | 8,022,463 | 8,016,516 | 36,926,285 | 35,963,706 | 35,751,956 | 268,468 | 35,262,233 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $6M | |
| Restructuring | $0 | · | · | · | $1M | · | · | · | · | · | · | $0 | $359.0K | $4M | · | · | |
| Operating Cash Flow | $-17M | $-16M | $-18M | $-17M | $-19M | $-24M | $-7M | $-16M | $-15M | $-22M | $-21M | $-24M | $-20M | $-20M | $-11M | $-12M | |
| CapEx | $37.0K | $21.0K | $84.0K | $175.0K | $140.0K | $119.0K | $1M | $5M | $6M | $6M | $2M | $6M | $6M | $2M | $5M | $-16.0K | |
| Investing Cash Flow | $-18M | $-32M | $15M | $8M | $-11M | $33M | $-3M | $-13M | $-102M | $-6M | $-2M | $-12M | $7M | $15M | $4M | $13M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Stock Issued | $-3M | $83M | · | · | $0 | $0 | · | $0 | · | · | $117M | $-1.0K | $-1.0K | $1.0K | $-60.0K | $-1.0K | |
| Net Stock Activity | · | $83M | · | · | · | · | · | · | · | · | · | · | · | $1.0K | · | · | |
| Financing Cash Flow | $-3M | $88M | $380.0K | $128.0K | $5.0K | $172.0K | $932.0K | $728.0K | $68M | $139.0K | $145M | $57M | $48M | $45M | $-238.0K | $56.0K | |
| Net Change in Cash | $-38M | $40M | $-2M | $-9M | $-31M | $9M | $-9M | $-28M | $-49M | $-27M | $122M | $22M | $34M | $41M | $-7M | $1M | |
| Taxes Paid | $60.0K | $48.0K | $0 | $0 | $1.0K | $0 | $94.0K | $0 | $30.0K | $17.0K | $0 | $0 | $27.0K | $0 | · | · | |
| Free Cash Flow | · | $-16M | · | · | · | $-25M | · | · | · | $-28M | · | · | · | $-14M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-15M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1764.9% | -1863.1% | -981.2% | · | · | · | · | · | · | · | -18313.4% | · | · | |
| Net Margin | · | · | · | -1657.0% | -1765.1% | -917.1% | · | · | · | · | · | · | · | -17449.1% | · | · | |
| Pretax Margin | · | · | · | -1657.0% | -1765.0% | -917.1% | · | · | · | · | · | · | · | -17427.7% | · | · | |
| EBITDA Margin | · | · | · | -1764.9% | -1863.1% | -981.2% | · | · | · | · | · | · | · | -18313.4% | · | · | |
| ROA | -11.0% | -10.2% | · | -8.9% | -12.0% | -11.7% | · | -14.5% | -13.3% | -13.1% | · | -12.7% | -9.4% | -14.7% | · | -11.6% | |
| ROE | -17.3% | -15.2% | · | -13.0% | -16.5% | -16.1% | · | -19.4% | -17.9% | -19.1% | · | -19.6% | -15.3% | -23.6% | · | -17.1% | |
| ROIC | -19.6% | -17.2% | · | -19.4% | -23.6% | -18.0% | · | -13.0% | -12.2% | -14.2% | · | -34.4% | -26.1% | -31.6% | · | -22.4% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.6 | 8.1 | · | 6.7 | 6.0 | 9.4 | · | 11.2 | 13.3 | 13.2 | · | 4.4 | 5.8 | 3.1 | · | 5.0 | |
| Quick Ratio | 9.1 | 7.7 | · | 6.3 | 5.6 | 8.9 | · | 10.1 | 12.8 | 12.6 | · | 4.3 | 4.8 | 1.9 | · | 2.2 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.2 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -72.2 | · | -77.1 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | 0.0 | · | 0.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.02 | $8.29 | · | $10.54 | $12.26 | $14.80 | · | $19.28 | $21.34 | $18.87 | · | $0.99 | $1.26 | $1.49 | · | $2.32 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.12 | $0.16 | $0.27 | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-1.39 | · | · | · | $-2.61 | · | · | · | $-2.73 | · | · | · | · | · | · | |
| Cash / Share | $1.69 | $4.28 | · | $2.57 | $3.58 | $6.83 | · | $6.78 | $9.82 | $17.30 | · | $1.13 | $1.10 | $1.14 | · | $1.24 | |
| EPS (TTM) | $-10.01 | $-11.68 | · | $-9.39 | $-9.73 | $-9.42 | · | $140.90 | $78.08 | $16.68 | · | $-426.70 | $-362.17 | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $4M | · | $7M | $6M | $5M | · | · | · | · | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-107M | $-113M | · | $-88M | $-91M | $-87M | · | $-88M | $-85M | $-81M | · | $-50M | $-51M | $-54M | · | $-86M | |
| Market Cap | $194M | $163M | · | $450M | $117M | $163M | · | $311M | $314M | $722M | · | $683M | $622M | $899M | · | $3.16B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $641M | $582M | $870M | · | $3.12B | |
| P/E | -1.3 | -1.0 | · | -5.1 | -1.3 | -1.8 | · | 0.2 | 0.4 | 5.4 | · | -0.0 | -0.0 | · | · | · | |
| P/S | 81.4 | 42.5 | · | 61.1 | 18.7 | 33.9 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 1.9 | 1.4 | · | 4.5 | 1.0 | 1.2 | · | 1.7 | 1.6 | 4.8 | · | 18.6 | 13.7 | 16.9 | · | 38.5 | |
| P / Tangible Book | 1.9 | 1.4 | · | 4.5 | 1.0 | 1.2 | · | 1.7 | 1.6 | 4.8 | · | 18.6 | 13.7 | 16.9 | · | 38.5 | |
| P / Cash Flow | · | -10.2 | · | · | · | -6.7 | · | · | · | -33.0 | · | · | · | -63.6 | · | · | |
| Earnings Yield | -75.9% | -103.2% | · | -19.6% | -77.9% | -54.1% | · | 421.6% | 230.5% | 18.5% | · | -2306.5% | -2093.5% | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $6M | $2M | $0 | $0 | $14M |
| Faaliyet Kâr Marjı % | -1906.4% | -4047.1% | · | · | -597.3% |
| Net Gelir | $-117M | $-84M | $-81M | $-58M | $-85M |
| Seyreltilmiş Hisse Başı Kâr | $-12.48 | $-9.37 | $-53.08 | $-227.42 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | · | · | · | 0.0 |
| Cari Oran | 6.9 | 8.8 | 8.9 | · | 11.8 |
| Cari Oran | 6.3 | 8.4 | 8.5 | · | 7.0 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-79M | $-78M | $-75M | · | $-79M |
Kurumsal Sahipler (13F) 114 dosya · $213.2M toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
114
Tutulan Değer
$213.2M
Yeni pozisyonlar
18
Çıkan pozisyonlar
11
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 18 (-15 önceki Ç'ye göre) | 11 (0 önceki Ç'ye göre) | 47 (+13 önceki Ç'ye göre) | 22 (-1 önceki Ç'ye göre) | +1.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Lynx1 Capital Management LP | $20.274.741 | 1.538.296 | 9,51% | Hisse senetleri |
| Qiming U.S. Ventures Management, LLC | $17.627.591 | 368.085 | 8,27% | Hisse senetleri |
| NEA Management Company, LLC | $17.106.230 | 1.297.893 | 8,02% | Hisse senetleri |
| Venrock Adviser, LLC | $13.305.210 | 1.009.500 | 6,24% | Hisse senetleri |
| Atlas Venture Life Science Advisors, LLC | $12.690.811 | 962.884 | 5,95% | Hisse senetleri |
| Balyasny Asset Management L.P. | $12.544.500 | 951.783 | 5,88% | Hisse senetleri |
| BlackRock, Inc. | $10.776.245 | 817.621 | 5,05% | Hisse senetleri |
| Affinity Asset Advisors, LLC | $9.316.995 | 706.904 | 4,37% | Hisse senetleri |
| Nantahala Capital Management, LLC | $8.699.274 | 660.036 | 4,08% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7.129.958 | 540.968 | 3,34% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $7.117.912 | 540.054 | 3,34% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.993.974 | 454.778 | 2,81% | Hisse senetleri |
| Driehaus Capital Management LLC | $5.931.593 | 450.045 | 2,78% | Hisse senetleri |
| TCG Crossover Management, LLC | $5.486.847 | 416.301 | 2,57% | Hisse senetleri |
| Kalehua Capital Management LLC | $5.338.427 | 405.040 | 2,50% | Hisse senetleri |
| Siren, L.L.C. | $4.582.923 | 347.718 | 2,15% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $3.940.478 | 298.974 | 1,85% | Hisse senetleri |
| VANGUARD GROUP INC | $3.922.009 | 489.639 | 1,84% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $3.913.148 | 296.870 | 1,84% | Hisse senetleri |
| 72 Investment Holdings, LLC | $3.648.633 | 276.831 | 1,71% | Hisse senetleri |
| STATE STREET CORP | $3.065.497 | 232.587 | 1,44% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.946.402 | 223.551 | 1,38% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $2.346.976 | 178.071 | 1,10% | Hisse senetleri |
| JPMORGAN CHASE & CO | $1.645.760 | 124.726 | 0,77% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $1.560.960 | 118.434 | 0,73% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $1.541.836 | 116.983 | 0,72% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $1.456.706 | 110.524 | 0,68% | Hisse senetleri |
| UBS Group AG | $1.389.871 | 105.453 | 0,65% | Hisse senetleri |
| NORTHERN TRUST CORP | $1.161.013 | 88.089 | 0,54% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $987.195 | 74.901 | 0,46% | Hisse senetleri |
| CITADEL ADVISORS LLC | $935.780 | 71.000 | 0,44% | Alım opsiyonu |
| F/m Investments LLC | $837.747 | 63.562 | 0,39% | Hisse senetleri |
| EMERALD MUTUAL FUND ADVISERS TRUST | $837.747 | 63.562 | 0,39% | Hisse senetleri |
| Walleye Capital LLC | $715.529 | 54.289 | 0,34% | Hisse senetleri |
| Quantinno Capital Management LP | $694.850 | 52.720 | 0,33% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $681.498 | 51.707 | 0,32% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $644.765 | 48.920 | 0,30% | Hisse senetleri |
| XTX Topco Ltd | $630.254 | 47.819 | 0,30% | Hisse senetleri |
| CITADEL ADVISORS LLC | $532.340 | 40.390 | 0,25% | Hisse senetleri |
| FMR LLC | $513.691 | 38.975 | 0,24% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $472.543 | 35.853 | 0,22% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $450.927 | 34.213 | 0,21% | Hisse senetleri |
| Jump Financial, LLC | $446.881 | 33.906 | 0,21% | Hisse senetleri |
| Bank of New York Mellon Corp | $418.196 | 31.730 | 0,20% | Hisse senetleri |
| AIHC Capital Management Ltd | $398.893 | 30.265 | 0,19% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $383.538 | 29.100 | 0,18% | Alım opsiyonu |
| Mariner, LLC | $367.824 | 27.908 | 0,17% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $346.028 | 26.254 | 0,16% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $337.039 | 25.572 | 0,16% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $317.770 | 24.110 | 0,15% | Hisse senetleri |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Atlas Venture Fund XI, L.P., Atlas Venture Associates XI, L.P., Atlas Venture Associates XI, LLC, Atlas Venture Opportunity Fund II, L.P., Atlas Venture Associates Opportunity II, L.P., Atlas Venture Associates Opportunity II, LLC ×2 başvurular | 04 Ağustos 2026 | 4,90% | Değişiklik | · | SEC |
| New Enterprise Associates 17, L.P., NEA Partners 17, L.P., NEA 17 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×3 başvurular | 12 Mart 2026 | 9,90% | Değişiklik | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 40 içeriden öğrenenler · 15 yöneticiler · 13 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Vineet Agarwal | Chief Financial Officer | 03 Şubat 2025 A | 0 | 0 | 0 | $0 |
| Peter P. Pfreundschuh | Chief Financial Officer | 22 Şubat 2022 S | 8.927 | 0 | 0 | $0 |
| Todd Chappell | Chief Operating Officer | 15 Temmuz 2026 A | 24.464 | 0 | 1 | $-34.309 |
| Oliver Dolan | Senior Vice President, Finance | 11 Eylül 2026 S | 16.241 | 0 | 4 | $-136.047 |
| Loic A Vincent | Chief Scientific Officer | 15 Temmuz 2026 A | 25.797 | 0 | 1 | $-37.017 |
| Jeffrey Cerio | General Counsel | 15 Temmuz 2026 A | 41.793 | 0 | 1 | $-71.575 |
| Olukemi Olugemo | Chief Medical Officer | 03 Şubat 2025 A | · | 0 | 0 | $0 |
| Shelby J. Walker | Senior Vice President, General Counsel and Secretary | 03 Kasım 2023 A | · | 0 | 0 | $0 |
| Steve Colletti | Chief Scientific Officer | 03 Kasım 2023 A | · | 0 | 0 | $0 |
| Richard J. Mitrano | VP Finance & Operations | 21 Ağustos 2023 S | 48.457 | 0 | 0 | $0 |
| Christopher R. Loose | Chief Scientific Officer | 28 Temmuz 2023 S | 183.650 | 0 | 0 | $0 |
| Quentin Mccubbin | Chief Manufacturing Officer | 26 Ocak 2023 A | 38.340 | 0 | 0 | $0 |
| Wendy S Arnold | Chief People Officer | 26 Ocak 2023 A | 21.186 | 0 | 0 | $0 |
| Carl Lebel | Chief Development Officer | 26 Ocak 2023 A | 26.343 | 0 | 0 | $0 |
| Michael Bookman | General Counsel and Secretary | 20 Nisan 2021 A | · | 0 | 0 | $0 |
| FORMELA JEAN FRANCOIS | Yönetim kurulu üyesi | 14 Eylül 2026 S | 132.650 | 0 | 24 | $-5.160.282 |
| Rachel Meyers | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| Katharine Knobil | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| Ali Behbahani | Yönetim kurulu üyesi | 10 Haziran 2026 A | 1.297.893 | 0 | 0 | $0 |
| Timothy R Pearson | Yönetim kurulu üyesi | 10 Haziran 2026 A | · | 0 | 0 | $0 |
| Nessan Bermingham | Yönetim kurulu üyesi | 10 Haziran 2026 A | 35.114 | 0 | 0 | $0 |
| David L. Lucchino | Yönetim kurulu üyesi | 11 Haziran 2024 A | 22.150 | 0 | 0 | $0 |
| Michael Huang | Yönetim kurulu üyesi | 17 Ağustos 2022 D | · | 0 | 0 | $0 |
| Cynthia L Feldmann | Yönetim kurulu üyesi | 17 Ağustos 2022 D | · | 0 | 0 | $0 |
| Robert Langer | Yönetim kurulu üyesi | 17 Ağustos 2022 D | 214.326 | 0 | 0 | $0 |
| Joel S Marcus | Yönetim kurulu üyesi | 17 Ağustos 2022 D | 307.116 | 0 | 0 | $0 |
| BARBERICH TIMOTHY J | Yönetim kurulu üyesi | 17 Ağustos 2022 D | 80.650 | 0 | 0 | $0 |
| Marc A Cohen | Yönetim kurulu üyesi | 21 Haziran 2022 A | 605.820 | 0 | 0 | $0 |
| Rick Yang | 10% sahip | 10 Mart 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Carmen Chang | 10% sahip | 10 Mart 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Mohamad Makhzoumi | 10% sahip | 10 Mart 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Anthony A. Florence, Jr. | 10% sahip | 10 Mart 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Paul Walker | 10% sahip | 10 Mart 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Edward T. Mathers | 10% sahip | 10 Mart 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Forest Baskett | 10% sahip | 10 Mart 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Scott D. Sandell | 10% sahip | 10 Mart 2026 P | 1.297.893 | 2 | 0 | $5.000.000 |
| Alexandria Venture Investments, LLC | 10% sahip | 07 Ekim 2019 C | 956.175 | 0 | 0 | $0 |
| William J. Mclean | 10% sahip | 02 Ekim 2019 A | · | 0 | 0 | $0 |
| Ram Aiyar | · | 04 Ağustos 2026 S | 69.046 | 0 | 2 | $-259.567 |
| Dana Charles Hilt | · | 20 Nisan 2021 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 15 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IWC · iShares Trust | 0,03% | 38.277 SH | 11 Eylül 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 7.950 SH | 19 Ağustos 2026 | Günlük |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2.113 SH | 02 Ekim 2026 | Günlük |
| IWO · iShares Trust | 0,01% | 58.538 SH | 11 Eylül 2026 | Günlük |
| IWM · iShares Trust | 0,00% | 281.853 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,00% | 5.318 NS | 31 Temmuz 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 9.978 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 3.332 SH | 03 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 135.396 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 311.262 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 63.717 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.170 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 428 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,00% | 28.271 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 82.104 SH | 11 Eylül 2026 | Günlük |
KRRO Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 18 analist
AL
Medyan hedef
$21.50
+123,0%
5 27,8%
Güçlü Al
11 61,1%
Al
2 11,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
10 analist · 2026-09-30Ortalama hedef $20.20 +109,5%
← Tüm hedeflerin altında
Mevcut fiyat $9.64
Düşük$10.00
Ortalama$20.20
Yüksek$30.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| HUMA | · | · | · | · | · | · |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026